London – October 02, 2026 -- Samfara has completed the acquisition of Chr. Olesen Synthesis, a Danish manufacturer of controlled-substance active pharmaceutical ingredients, marking the London-based life sciences investment firm's first deal. The transaction sees Samfara buy the business from Chr. Olesen and funds managed by Signet Healthcare Partners, with Chief Executive Thomas Moestrup co-investing alongside the new owner. Financial terms were not disclosed.

Suzhou – October 02, 2026 -- Novartis has agreed to pay Abogen Biosciences an upfront fee of USD 575 million to secure worldwide rights to ABO2203, an mRNA-encoded CD19xCD3 T-cell engager for autoimmune diseases, with total deal value reaching up to approximately USD 7.2 billion if all milestones and options are exercised.

Toronto – October 01, 2026 -- Manulife Financial Corporation has closed a reinsurance transaction transferring biometric risk on a block of long-term care policies carrying $3.2 billion in reserves to Munich American Reassurance Company, a US subsidiary of Munich Re Group.

Mansfield, Massachusetts – October 01, 2026 -- Samsonite Group S.A. has completed its acquisition of BÉIS, LLC, the digitally native lifestyle and travel brand founded in 2018 by actress and entrepreneur Shay Mitchell.

Dallas – – October 01, 2026 -- Sekisui Specialty Chemicals will raise prices on its Selvol Polyvinyl Alcohol, Selvol Ultiloc, Selvol Ultalux, and Selvol Premiol product lines effective October 15, 2026, or as existing contracts and agreements permit.

Salt Lake City – October 01, 2026 -- Banner Capital has formed Seaway Group and signed a definitive agreement to acquire three medical device manufacturing businesses -- Seaway Plastics Engineering, MME Group and Wright Engineered Plastics -- in a transaction expected to close in the fourth quarter of 2026, subject to customary closing conditions.

Santa Monica, Calif. – October 01, 2026 -- Starz (NASDAQ: STRZ) will release third-quarter 2026 financial results on Thursday, October 29, covering the period ended September 30, 2026.

Starz schedules investor call after market close on October 29

Senior management will host an analyst and investor conference call at 2:00 PM PT / 5:00 PM ET on October 29, following the earnings release. The session will be available via live audio webcast, with a full replay accessible later the same evening.

Columbia, Mo. – October 01, 2026 -- American Outdoor Brands, Inc. (NASDAQ: AOUT) has authorized a new share repurchase program of up to $10 million, running from October 1, 2026 through September 30, 2027.

Prior buyback program closed with $1.9 million deployed

The new authorization follows a predecessor program, launched in 2025 with an identical $10 million ceiling. As of September 30, 2026, that program had repurchased 236,907 shares at an average price of $8.15, totaling roughly $1.9 million, well below its full capacity.

Birmingham, Ala. – October 01, 2026 -- Encompass Health Corp. (NYSE: EHC) will release third-quarter 2026 financial results after market close on Wednesday, Oct. 28, 2026.

Company schedules investor call for Oct. 29 at 10 a.m. ET

Encompass Health will host a conference call the following morning to discuss the quarterly results with investors. Domestic participants can dial 833-354-6854 using conference ID EHCQ326, while international callers should use 785-838-9343 with the same ID.

Mexico City – October 01, 2026 -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) will release its Third Quarter 2026 earnings results on Wednesday, October 21, 2026, after the close of the Mexican Stock Exchange.